Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teppei Matsui

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Biological & Pharmaceutical Bulletin|September 4, 2020
Tivantinib Decreases Hepatocyte Growth Factor-Induced BCRP Expression in Hepatocellular Carcinoma HepG2 CellsKojiro Kobayashi, Koji Higai, Takanori Mukozu, et al.
Oncology|February 25, 2024
Remaining Issues Related to Serum Cytokines in Patients with Unresectable Hepatocellular Carcinoma Treated by Atezolizumab plus Bevacizumab Combination TreatmentHidenari Nagai, Takanori Mukozu, Teppei Matsui, et al.
Journal of Gastroenterology|April 18, 2013
Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patientsKazumoto Murata, Masaya Sugiyama, Tatsuji Kimura, et al.
Journal of Ultrasound|October 7, 2018
Hepatic arterialization can predict the development of collateral veins in patients with HCV-related liver diseaseNoritaka Wakui, Hidenari Nagai, Yu Ogino, et al.
Anticancer Research|April 7, 2019
Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by EtiologyHidenari Nagai, Takanori Mukozu, Kojiro Kobayashi, et al.
European Journal of Gastroenterology & Hepatology|September 28, 2022
Measurement of skeletal muscle volume is useful for predicting prognosis in patients with liver cirrhosisTeppei Matsui, Hidenari Nagai, Gou Watanabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 28, 2012
Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patientsHiroaki Saito, Kiyoaki Ito, Masaya Sugiyama, et al.
Ultrasound Quarterly|April 11, 2018
Effect of Hepatic Inflammation in Chronic Hepatitis C Infection on Fibrosis Assessment by Arrival Time Parametric ImagingNoritaka Wakui, Hidenari Nagai, Yasushi Matsukiyo, et al.
Ultrasound in Medicine & Biology|October 28, 2025
The Bubble-Destruction Curve Obtained Using Contrast-Enhanced Ultrasound is Useful for Assessing Liver Fibrosis and Identifying At-risk MASH in Patients With MASLDNoritaka Wakui, Yu Ogino, Naohisa Kamiyama, et al.
Oncology|June 26, 2023
Effects of Lenvatinib on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular CarcinomaHidenari Nagai, Makoto Amanuma, Takanori Mukozu, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Biological & Pharmaceutical Bulletin|September 4, 2020
Tivantinib Decreases Hepatocyte Growth Factor-Induced BCRP Expression in Hepatocellular Carcinoma HepG2 CellsKojiro Kobayashi, Koji Higai, Takanori Mukozu, et al.
Oncology|February 25, 2024
Remaining Issues Related to Serum Cytokines in Patients with Unresectable Hepatocellular Carcinoma Treated by Atezolizumab plus Bevacizumab Combination TreatmentHidenari Nagai, Takanori Mukozu, Teppei Matsui, et al.
Journal of Gastroenterology|April 18, 2013
Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patientsKazumoto Murata, Masaya Sugiyama, Tatsuji Kimura, et al.
Journal of Ultrasound|October 7, 2018
Hepatic arterialization can predict the development of collateral veins in patients with HCV-related liver diseaseNoritaka Wakui, Hidenari Nagai, Yu Ogino, et al.
Anticancer Research|April 7, 2019
Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by EtiologyHidenari Nagai, Takanori Mukozu, Kojiro Kobayashi, et al.
European Journal of Gastroenterology & Hepatology|September 28, 2022
Measurement of skeletal muscle volume is useful for predicting prognosis in patients with liver cirrhosisTeppei Matsui, Hidenari Nagai, Gou Watanabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 28, 2012
Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patientsHiroaki Saito, Kiyoaki Ito, Masaya Sugiyama, et al.
Ultrasound Quarterly|April 11, 2018
Effect of Hepatic Inflammation in Chronic Hepatitis C Infection on Fibrosis Assessment by Arrival Time Parametric ImagingNoritaka Wakui, Hidenari Nagai, Yasushi Matsukiyo, et al.
Ultrasound in Medicine & Biology|October 28, 2025
The Bubble-Destruction Curve Obtained Using Contrast-Enhanced Ultrasound is Useful for Assessing Liver Fibrosis and Identifying At-risk MASH in Patients With MASLDNoritaka Wakui, Yu Ogino, Naohisa Kamiyama, et al.
Oncology|June 26, 2023
Effects of Lenvatinib on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular CarcinomaHidenari Nagai, Makoto Amanuma, Takanori Mukozu, et al.
Pageof 7